Copyright
©The Author(s) 2002.
World J Gastroenterol. Apr 15, 2002; 8(2): 298-300
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.298
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.298
Group | n | CD3+ | CD4+ | CD8+ | CD4+/CD8+ | mIL-2R | |
Silent | Induced | ||||||
Anti-HCV (+)AH | 58 | 0.62 ± 0.05a | 0.37 ± 0.05b | 0.35 ± 0.07a | 1.18 ± 0.30 | 0.03 ± 0.01b | 0.34 ± 0.02b |
Anti-HCV (-)CH | 145 | 0.61 ± 0.07b | 0.37 ± 0.05b | 0.36 ± 0.06b | 1.04 ± 0.42b | 0.03 ± 0.01b | 0.35 ± 0.02b |
Normal controls | 20 | 0.66 ± 0.07 | 0.41 ± 0.06 | 0.31 ± 0.05 | 1.39 ± 0.33 | 0.04 ± 0.02 | 0.36 ± 0.03 |
F | - | 5.32 | 6.45 | 5.96 | 7.08 | 8.33 | 9.05 |
P | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | < 0.01 | |
MS within group | 40.347 | 26.186 | 32.022 | 0.150 | 1.39 | 5.354 |
- Citation: Li CP, Wang KX, Wang J, Pan BR. mIL-2R, T cell subsets and hepatitis C. World J Gastroenterol 2002; 8(2): 298-300
- URL: https://www.wjgnet.com/1007-9327/full/v8/i2/298.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i2.298